Gravesteijn, A. S. http://orcid.org/0000-0002-2458-2346
Beckerman, H.
de Jong, B. A.
Hulst, H. E.
de Groot, V.
Funding for this research was provided by:
Stichting MS Research (18-358f MS)
Article History
Received: 1 April 2020
Accepted: 4 May 2020
First Online: 11 May 2020
Ethics approval and consent to participate
: This study has been approved by the medical ethical review committee of VU University medical center (METc 2019.676, protocol version 5 date 22-01-2020) and is reviewed and approved by the scientific research committee of Amsterdam Neuroscience research institute (CWO nr.19.27). All amendments, i.e. changes made to the research protocol after a favorable opinion by the METc, will be notified to the METc.The participant information letter informs about aims, background, measurements, interventions, possible benefits and risks, use of body material (blood sampling), privacy and contact information, including contact information of the independent expert. Before participation participants at least have one week to decide whether to participate based on information in the participant information letter. During this period people have the opportunity to discuss participation with family members, friends, the researcher and an independent expert. Prior to any research-related activities, participants must sign the informed consent form. Informed consent will be signed during the first visit by the participant and researcher.
: Consent for publication of the photographs in Additional file InternalRef removed was obtained.
: BJ has received speaker and consulting fees from Merck-Serono, Biogen, TEVA, Genzyme, and Novartis. HH received honoraria for speaking at scientific meetings, serving at scientific advisory boards and consulting activities from, Biogen, Celgene, Genzyme, Merck, and Roche. She has received research support from the Dutch MS Research foundation and serves on the editorial board of MSJ. VG, HB, AG declare to have no competing interests.